NCT03116750View on ClinicalTrials.gov

Post-Market Clinical Follow-up Study with ASPIREX®S to Assess the Safety and Effectiveness in the Treatment of DVT

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

April 3, 2017

Primary Completion Date

December 30, 2021

Study Completion Date

June 6, 2024

Conditions

Deep Vein ThrombosisBypass ComplicationDialysis ShuntStent Occlusion

Trial Locations (9)

18057

Institut für Diagnostische und Interventionelle Radiologie, Universitätsklinik Rostock, Rostock

21079

CHU - Hôpital François-Mitterrand, Dijon

59755

Klinikum Arnsberg, Klinik für Angiologie, Arnsberg

Unknown

Medizinische Universität Graz, Graz

Medizinische Universität Wien, Vienna

Universitätsklinikum Aachen, Aachen

Universitätsklinikum Heidelberg, Heidelberg

Azienda Ospedaliera San Giovanni Addolorata, Roma

H91YR71

Galway University Hospital, Galway

All Listed Sponsors

lead

Straub Medical AG

INDUSTRY

NCT03116750 - Post-Market Clinical Follow-up Study with ASPIREX®S to Assess the Safety and Effectiveness in the Treatment of DVT | Biotech Hunter | Biotech Hunter